CORAL Study: Proof of Concept Trial (CORAL)

November 1, 2011 updated by: Claire Henderson, MRCPsych MSc PhD, Institute of Psychiatry, London

The CORAL Study of a Decision Aid Tool Regarding Disclosure of Mental Health Status to an Employer: Proof of Concept Randomised Control Trial

A decision aid tool (DAT) to assist mental health service users in reaching disclosure decisions in the context of employment was developed in a previous study (IRAS REC ref: 07/Q0706/21). The initial feasibility and acceptability was assessed in a group of 15 mental health service users with mean decisional conflict scores reduced from 51.98 to 35.52 after completion. 60% of participants reported that the DAT was quick to complete, 40% that it was easy, 60% that it was relevant and 80% that they would definitely or probably use it in making disclosure decisions. This current study (CORAL: Proof of concept RCT) aims to determine whether a full randomised controlled trial of the DAT is justifiable and feasible, and to optimise its design. This will consider: 1) effects of the intervention; 2) baseline predictors of disclosure; and 3) exploration of the relationship between use of the DAT and the rate of disclosure.

Eighty people who are on the caseload of a vocational specialist working with people with mental illness will be included in this study. All participants will be receiving treatment from an Improving Access to Psychological Therapies (IAPT) service or a Community Mental Health Team (CMHT). An equal number from each group will be allocated to receive either the DAT intervention or treatment as usual. Individuals from both groups will complete baseline assessment and 3month followup assessments. Those allocated to the intervention will also complete an assessment immediately following the intervention. Qualitative interviews will also be conducted at 3 months with a maximum of 15 people from the intervention group and 6 people from the control group.

Study Overview

Status

Unknown

Conditions

Detailed Description

The principal aims are to determine whether a full randomised controlled trial of the CORAL decision aid tool is justifiable and feasible and to optimise its design. Specific objectives are as follows:

  1. To examine the effect of the DAT on decisional conflict regarding disclosure both immediately and at 3 months post first use.
  2. To collect data to inform sample size calculations for the primary outcome measures for use in a future full scale trial(gaining employment and workplace accommodations).
  3. To test study procedures, including the sample that can be drawn using the inclusion and exclusion criteria; the full time equivalent needed for research assistants to recruit sufficient numbers and carry out the study procedures in the time available; and whether the measure leads to too much respondent burden.
  4. To pilot the use of a questionnaire on employment and disclosure related activities.
  5. To test the selected randomisation method, in this case individual level randomisation, including the methods for avoiding and measuring contamination.
  6. To pilot recruitment and retention methods for service users and vocational specialists.
  7. To estimate effect sizes and their confidence intervals for employment related activities (proxy outcome measures for gaining employment and workplace accommodations), in order to determine whether a full scale trial is justified.
  8. To modify the conceptual model

Study Type

Interventional

Enrollment (Anticipated)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • London, United Kingdom, SE5 8AF
        • Recruiting
        • Institute of Psychiatry, King's College London

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. On the caseload of a vocational specialist working with people with mental illness.
  2. Referred to the adviser either from an Increased Access to Psychological Therapies or secondary mental health care service.
  3. Aged 18 years or older
  4. Currently seeking either paid or voluntary employment or interested in seeking paid or voluntary employment
  5. Decisional conflict scale score of 37.5 or greater and stage of decision score 1-5

Exclusion Criteria:

  1. Insufficient English to use the decision aid tool
  2. Lack of capacity to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Decision Aid Tool
Intervention group - receives the decision aid tool in booklet form and is introduced to it by an investigator.
A booklet which outlines to pros and cons of different decision outcomes, and is designed to assist the user in making a decision according to their own specific circumstances
No Intervention: Control
The control group does not receive a copy of the decision aid tool booklet, instead received treatment as usual from vocational specialist
The control group does not receive a copy of the decision aid tool booklet, instead received treatment as usual from vocational specialist

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
decisional conflict scale
Time Frame: Change from baseline in decisional conflict at 3 months
Decisional conflict scale (O'Connor, 1993) This measures personal perceptions of uncertainty, lack of clarity and effectiveness in decision making. Has 16 items with each rated on a 5 point Likert scale ranging from 0=strongly agree to 4=strongly disagree.
Change from baseline in decisional conflict at 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sociodemographic data
Time Frame: baseline
Socio-demographic and clinical data to be collected as part of the baseline interview will include age, gender, years since first contact with mental health services, education, employment status and history, housing arrangements, source of income, current mental health care, knowledge of clinical diagnosis, agreement with diagnosis and information on social networks.
baseline
Employment related questions
Time Frame: baseline and 3-month follow up
To record how many jobs applications, apppointments with vocational specialists, training days and job applications the participant has completed in the preceeding 3 months.
baseline and 3-month follow up
Discrimination and Stigma Scale (DISC)
Time Frame: Baseline and 3-month follow-up

scale to assess mental health service users' experiences of discrimination. 22 items. Baseline assesses if discrimination/stigma has ever been experienced, 3 month follow-up asks if discrimination/stigma as been experienced in the past three months.

Thornicroft, G., Brohan, E., Rose, D., Sartorius, N. & the INDIGO study group. (2009) Global pattern of experienced and anticipated discrimination against people with schizophrenia. The Lancet, 373 (9661), 408-415

Baseline and 3-month follow-up
Questionnaire on Anticipated Discrimination (QUAD)
Time Frame: baseline and 3 month follow-up

The QUAD is a self-complete measure which contains 17 items which address 'areas of anticipated discrimination'. This asks participants to provide a rating of whether they expect to be treated unfairly in various areas of life. Each item is scored on a five point Likert scale ranging from 0 (Strongly disagree) to 4 (Strongly agree).

Brohan E, Clement S, Thornicroft G. Development and initial validation of the questionnaire on anticipated discrimination (QUAD v6, May 2011) © 2011, Institute of Psychiatry, King's College London

baseline and 3 month follow-up
Boston University Empowerment Scale (BUES)
Time Frame: baseline and 3 month follow-up

This 28-item scale was developed with an emphasis on service user-involvement at all stages of design and testing. This version has shown adequate internal consistency (α=.86).

Rogers, E. S., Chamberlin, J., Ellison, M. L., et al (1997) A consumer-constructed scale to measure empowerment among users of mental health services. Psychiatric Services, 48, 1042-1047.

baseline and 3 month follow-up
Internalised Stigma of Mental Illness Scale (ISMI)
Time Frame: Baseline and 3 month follow-up
The ISMI is a 29-item measure that assesses mental health service users' experience of internalised stigma. It is composed of 5 sub-scales: Alienation, Stereotype Endorsement, Perceived Discrimination, Social Withdrawal and Stigma Resistance. Strong internal consistency (α = 0.90) and test-retest reliability(r=0.92) have been reported Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: Psychometric properties of a new measure. Psychiatry Research 2003;121(1):31-49.
Baseline and 3 month follow-up
Perceived Devaluation and Discrimination Scale (PDD)
Time Frame: Baseline and 3 month follow-up

The PDD is a 12-item, uni-dimensional, scale which measures the extent to which a person believes that people will devalue or discriminate against those with a mental illness. This scale has been widely used and has excellent psychometric properties

Link, B.G., Neese-Todd, S., Asmussen, S. & Phelan, J.C. (2002). On describing and seeking to change the experience of stigma. Psychiatric Rehabilitation Skills, 6: 201-231.

Baseline and 3 month follow-up
Stigma Coping Orientation Scales
Time Frame: baseline and 3 month follow-up

Measures to assess approaches to coping with the stigma associated with mental illness. Revised versions of four of the scales are now available and will be used in this study. These are secrecy (5-items alpha = .85), withdrawal (5-items alpha = .71), challenging (5 items alpha = .75) and distancing (3 items alpha = .62) (Bruce Link, personal communication).

The Effectiveness of Stigma Coping Orientations: Can Negative Consequences of Mental Illness Labeling be Avoided? Bruce G. Link, Jerrold Mirotznik, Francis T. Cullen, Journal of Health and Social Behavior, Vol. 32, No. 3 (Sep., 1991)

baseline and 3 month follow-up
Brief COPE
Time Frame: Baseline and 3-months Follow-up

A short-version COPE Inventory. Assesses response to stress. 14 scales with two items each; self-distraction, active coping, denial, substance use, use of emotional support, use of instrumental support, behavioral disengagement, venting, positive reframing, planning, humor, acceptance, religion and self-blame. Reliability analyses exceeded alpha=0.60, except for venting, denial and acceptance, all of which exceed alpha = 0.50 (Carver et al 1997)

Carver, C. S. (1997). International Journal of Behavioral Medicine, 4, 92-100

Baseline and 3-months Follow-up
Work Limitations Questionnaire (WLQ)
Time Frame: Baseline and 3 month follow-up (for those in employment only)

The 8-item short WLQ measures the degree to which employed individuals are experiencing limitations on-the-job due to their health problems, and health-related productivity loss.

Work Limitations Questionnaire, 1998. The Health Institute, Tufts Medical Center, 800 Washington Street, Nemc #345, Boston, MA 02111

Baseline and 3 month follow-up (for those in employment only)
stage of decision making scale
Time Frame: Baseline and 3 month follow-up
Stage of decision making scale (O'Connor, 2000).This measures the individual's readiness to engage in decision making It consists of 1 item with 6 response options anchored at 1 (haven't started to think about the choices) and 6 (have already made a decision and am unlikely to change my mind).
Baseline and 3 month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Graham Thornicroft, FRCPsych, Institute of Psychiatry, London

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (Anticipated)

March 1, 2013

Study Completion (Anticipated)

March 1, 2013

Study Registration Dates

First Submitted

June 17, 2011

First Submitted That Met QC Criteria

June 22, 2011

First Posted (Estimate)

June 23, 2011

Study Record Updates

Last Update Posted (Estimate)

November 2, 2011

Last Update Submitted That Met QC Criteria

November 1, 2011

Last Verified

November 1, 2011

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Illness

Clinical Trials on Decision Aid Tool

Subscribe